Steven Myint

Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research.

Part of GSK Plc, GlaxoSmithKline Oy is a Finnish company that manufactures pharmaceutical products. The company is based in Espoo, Finland.

Part of Boston Scientific Corp., BTG International Ltd. is a British company that engages in research and experimental development on natural sciences and engineering. The company is based in London, UK and was founded in 1991.

Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland.

Inex Innovations Exchange Pte Ltd provides molecular diagnostics services. The firm specializes in FemTech – technology that addresses specific concerns on women’s health, such as reproductive health and ovarian cancer. The company was founded by Mahesh Choolani, Sidney Yee, Khalil Razvi and Arijit Biswas in 2006 and is headquartered in Singapore.

Vickers Vantage Corp. I is a blank check company. It is created for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 21, 2020 and is headquartered in Singapore.